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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   
 



















 The majority of COVID-19 
patients are male. COVID-
19 comorbidities were 
found in several patients. 
The main clinical 
symptoms of COVID-19 in 
this study were cough, 
sore throat, and fever.  
 The abnormal laboratory 
finding in COVID-19 
patients is anemia, an 
increase in AST and ALT 
levels, and chest x-ray 
images of pneumonia. All 
patients are in mild 
condition. The average 
length of hospital 
admission patients to 
discharge is more than 30 
days.  
 The inability of a local 
laboratory to check for 
positive confirmation of 
COVID-19 makes the 
admission period of the 
patient in the hospital very 
 Morbidity 
2 
long. The availability of RT-
PCR tests at Abdul Wahab 
Sjahranie Hospital 
Samarinda will greatly 
assist the further 
management of COVID-19 
patients.. 

























 This study assesses the 
potential impact of 
different control measures 
for mitigating the burden 
of COVID-19 in the UK. 
 The four base 
interventions modelled 
were school closures, 
physical distancing, 
shielding of people aged 
70 years or older, and 
self-isolation of 
symptomatic cases. 
 Conclusion that intensive 
interventions with 
lockdown periods would 
need to be in place for a 
large proportion of the 






















 People with COVID-19 
are unlikely to spread the 
new coronavirus if more 
than eight days have 
passed since their 
symptoms began, 
according to experiments 





 Hospital patients who still 
test positive for viral RNA 
weeks after they began 
feeling ill might not need 














Saharan Africa and 



















warning labels for 















 The high 
prevalence of 
variants in the 
G6PD gene found 
in this analysis 
suggests that it 
may be a 
significant 
interaction factor 
in clinical trials of 
chloroquine and 
hydrochloroquine 


























 Pakistani residents had 
good knowledge and 
practices towards COVID-
19 yet there are gaps in 
specific aspects of 
knowledge, and practice 
that should be focused in 
future awareness and 
educational campaigns.  
 Study recommends the 
ministry of health 
authorities promote all 
precautionary and 
preventive measures of 
COVID-19 - to all strata of 
society including less 
privileged people, older 
ones and less educated 
people. 
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02.06.20 Hydroxychloroquine or chloroquine 
with or without a macrolide for 
treatment of COVID-19: a multinational 
registry analysis 
Lancet | Expression of 
concern 
  
June 2020 Initiation of the Global Coalition for 
Radiotherapy during the COVID-19 
pandemic 





02.06.20 Global mental health and COVID-19 Lancet Psychiatry | 
Comment 
Lola Kola 
02.06.20 The need for privacy with public digital 
contact tracing during the COVID-19 
pandemic 





Janda et al 
5 
02.06.20 Thousands of people will help 
scientists to track the long-term health 
effects of the coronavirus crisis 
Nature |News   
02.06.20 A Harm-Reduction Approach to 
Coronavirus Disease 2019 (COVID-
19)—Safer Socializing 






26.05.20 Why Africa struggles to test for covid-
19 
The Economist | News   
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
01.06.20 Basic Psychosocial 




 This Guide aims to help orient people 
supporting the COVID-19 response to 
integrate psychosocial support skills 
into their daily work, thereby making 
a difference to the well-being of 
people they come into contact with 
during the pandemic.  
 The guide advises how to help others 
find their own solutions to their 
problems. 
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C19 Resource Hubs 






















LSTM Stop TB 
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Johns Hopkins University RBM 
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Evidence-based Medicine 
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Online learning & events 





Alumni webinar #5 - 
Corona in Kenya: 
interventions, 
challenges, lessons 
learnt and the way 
forward 







Online course I hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 




Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 





on COVID-19 and 
Development: John 
Nkengasong 
Event   CGD 
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 






















5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
13 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
